π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study was to assess the safety, tolerability, and preli...
Status
Terminated
Location
H Lee Moffitt Cancer Center and Research Institute Inc
Start Date
2018-07-18
Trial ID
NCT03549000
The primary objective of the trial was to characterize the safety, tolerabi...
Status
Terminated
Location
University Of California LA
Start Date
2020-02-20
Trial ID
NCT04237649
This is a Phase Ib, open label, dose escalation study of spartalizumab + LA...
Status
Terminated
Location
Columbia University Medical Center- New York Presbyterian Columbia
Start Date
2019-01-31
Trial ID
NCT03742349
Treatments Being Tested
The purpose of this phase 2 study is to evaluate the efficacy and safety of...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2017-08-28
Trial ID
NCT03207867
This was a first in human study of DFF332, a small molecule that targets a ...
Status
Terminated
Location
City of Hope National Medical
Start Date
2021-11-30
Trial ID
NCT04895748